An experimental vaccine on Alzheimer's disease could halve the number of dementias



[ad_1]

Breakthrough in the treatment of dementia?

The researchers have now discovered that an experimental vaccine against Alzheimer's disease could halve the number of cases of dementia and delay the effects of a five-year-old degenerative brain disease.

Researchers at the University of Texas Southwestern Medical Center have discovered in their current research that an experimental vaccine against Alzheimer's disease could dramatically reduce the number of cases of dementia. The doctors published the results of their study in the English language journal "Alzheimer's Research & Therapy".

A new drug could halve the number of cases of dementia in the future. (Image: Photographer.eu/fotolia.com)

The vaccine has shown promising results in animal experiments

The new vaccine has shown promising results in recent animal experiments, experts said. The researchers hope that the vaccine will also have similar effects in humans. The transition from animal experimentation to human use is long and tedious, and many promising remedies do not make this leap. If vaccines prove to be safe and effective in human trials, they could halve the total number of diagnoses for dementia, said the study's authors.

Vaccines against Alzheimer's disease often have harmful side effects

Dementia is the general term used to describe symptoms of cognitive decline involving memory, thinking and behavior problems. Alzheimer's disease is the leading cause of dementia, doctors say. The new experimental vaccine marks a monumental advance in the fight against dementia. According to the authors, previous vaccinations against Alzheimer's disease had resulted in harmful side effects, including inflammation of the brain.

First successful tests!

Recent tests on monkeys and rabbits have shown that the new vaccine stimulates the body's production of antibodies that reduce the accumulation of amyloid and tau. These two proteins usually indicate a degenerative brain disease. Scientists hope the vaccine could prolong people's lives and prevent the disease from spreading to the brain.

The vaccine appears to prevent the accumulation of protein

If drugs could delay the onset of the disease by five years, it would be a great step forward for patients and their families. This could halve the number of cases of dementia. The new vaccine appears to be able to stop the build-up of abnormal protein structures in the brain and the death of nerve cells without causing autoimmune inflammation, the researchers wrote in a press release from the Southwestern Medical Center of the United States. University of Texas.

Does Herpes Cause Alzheimer's Disease?

According to Alzheimer's Association, the disease is the sixth most common cause of death in the United States. About 5.7 million Americans currently live with Alzheimer's disease and researchers estimate that this number will increase to 14 million by 2050. Between 2000 and 2015, the number of deaths due to Alzheimer's disease Alzheimer's disease increased by 123%.

A professor at the University of Manchester recently said that nearly half of Alzheimer's disease is caused by herpes viruses. A connection that was unknown until now. According to the World Health Organization (WHO), about 3.7 billion people under the age of 50 (more than 50% of the world's population) are infected with the herpes simplex virus-type 1. (As)

[ad_2]
Source link